Champions Biotechnology Inc. (CSBR.OB) Obtains Exclusive License for Cancer Treatment in Collaboration with Yale and Southern Research Institute
QualityStocks (November 18th, 2009) Writes:
Champions Biotechnology Inc. focuses on oncology drug developments and preclinical platforms and data to enhance and accelerate the value of those drugs. The company today announced an exclusive licensing agreement with Yale University and Southern Research Institute for the development of Bithionol for cancer treatment.
According to scientists from Yale and Southern Research, Bithionol, which is available for parasitic infections, shows activity against solid cancerous tumors and may be effective in treating melanoma, prostate, breast, lung and other cancers.
Per the agreement, Yale and Southern Research will receive an upfront payment, as well as milestone payments and royalties; Champions has exclusive rights for continued development of Bithionol for all oncology applications, and will use its predictive Biomerk Tumorgraft platform to determine optimal applications and efficient clinical development. If Champions is able to deliver results, the company will conduct human clinical trials.
“We are excited to work with Champions’ experienced scientific
...Associate Professor, associate professor of pathology, Biotechnology Inc., Bithionol, cancer, Cancer Treatment, Cancers, Demetrios Braddock, Investing Lessons, licensed technology, Melanoma, Nancy M. Gray, oncology applications, parasitic infections, professor of pathology, Small & Micro Cap, Southern Research Institute, tumors, Vice President of Corporate Development, Yale School of Medicine, Yale University


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)




Robert Shiller
Professor of
Economics
Yale University
Karl Case
Professor of
Economics
Wellesley College
Sam Masucci
President, CEO
and Co-Founder
MacroMarkets
Please join us for an in-depth discussion on Real Estate Investing: Risk Management, Transparency & Liquidity, with world-renowned economists Karl Case and Robert Shiller, at the historic New York Stock Exchange, on May 1, 2009.
The presentation coincides with the initial public offering of the MacroShares Major Metro Housing, the first exchange-traded products allowing investors access to this $18 trillion asset class and the ability to either ... 